Notice2026-00941
Notice Pursuant to the National Cooperative Research and Production Act of 1993-Rapid Response Partnership Vehicle
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 20, 2026
Issuing agencies
Justice DepartmentAntitrust Division
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 12 (Tuesday, January 20, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 12 (Tuesday, January 20, 2026)]
[Notices]
[Pages 2370-2371]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-00941]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Rapid Response Partnership Vehicle
Notice is hereby given that, on July 7, 2025, pursuant to section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), Rapid Response Partnership
Vehicle (``RRPV'') has filed written notifications simultaneously with
the Attorney General and the Federal Trade Commission disclosing
changes in its membership. The notifications were filed for the purpose
of extending the Act's provisions limiting the recovery of antitrust
plaintiffs to actual damages under specified circumstances.
Specifically, Alveo Technologies, Inc., Alameda, CA; Arcology,
Inc., Culver City, CA; Athari BioSciences, Sterling, VA; BIOQUAL, Inc.,
Rockville, MD; BioFactura, Inc., Frederick, MD; Biomeme, Inc.,
Philadelphia, PA; Commense Bio, Inc., Boulder, CO; Deloitte Consulting
LLP, Arlington, VA; Faro Molecular, Inc., Salt Lake City, UT; Fluxergy,
Irvine, CA; Global Key Solutions Corp., New York, NY; HYUNDAI
BIOSCIENCE USA, Inc., San
[[Page 2371]]
Jose, CA; NOVODX Corporation, Tequesta, FL; NanoPass Technologies,
Ltd., Nes Ziona, STATE OF ISRAEL; NanoViricides, Inc., Shelton, CT;
Naval Health Research Center, San Diego, CA; Proactive Dx, Thousand
Oaks, CA; Proteios Technology, Inc., Issaquah, WA; READDI, Inc.,
Research Triangle Park, NC; REDAN LLC, Silver Spring, MD; Research &
Development Plus LLC, Charleston, SC; Resonantia Diagnostics, Inc.,
Durham, NC; Revolution Biomanufacturing, Inc., Canton, MA; Science
Systems and Applications, Inc., Lanham, MD; Signum Technologies, Inc.,
Radnor, PA; Smart World LLC, Fremont, CA; Spectral Platforms, Inc.,
Duarte, CA; The University of Utah, Salt Lake City, UT; University of
Maryland Baltimore, Baltimore, MD; University of Missouri System dba
Curators of the University of Missouri, Columbia, MO; and Virongy
Biosciences, Inc., Manassas, VA; have been added as parties to this
venture.
Also, Asha Therapeutics LLC, Tampa, FL; Endpoint Health, Palo Alto,
CA; Kudo Biotechnology, Inc., Needham, MA; PIF Partners LLC, Englewood,
NJ; and QUZE Pharmaceuticals, Inc., Windsor, CO; have withdrawn as
parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and RRPV intends to file additional
written notifications disclosing all changes in membership.
On January 5, 2024, RRPV filed its original notification pursuant
to section 6(a) of the Act. The Department of Justice published a
notice in the Federal Register pursuant to section 6(b) of the Act on
April 16, 2024 (89 FR 26928).
The last notification was filed with the Department on April 8,
2025. The Department of Justice published a notice in the Federal
Register pursuant to section 6(b) of the Act on June 13, 2025 (90 FR
25080).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2026-00941 Filed 1-16-26; 8:45 am]
BILLING CODE P
</pre></body>
</html>Indexed from Federal Register on January 20, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.